- Home
- TMCI vs ETON Comparison
TMCI vs ETON Comparison
Compare TMCI & ETON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TMCI
- ETON
- Stock Information
- Founded
- TMCI 2014
- ETON 2017
- Country
- TMCI United States
- ETON United States
- Employees
- TMCI N/A
- ETON N/A
- Industry
- TMCI Biotechnology: Electromedical & Electrotherapeutic Apparatus
- ETON Biotechnology: Pharmaceutical Preparations
- Sector
- TMCI Health Care
- ETON Health Care
- Exchange
- TMCI Nasdaq
- ETON Nasdaq
- Market Cap
- TMCI 371.1M
- ETON 428.5M
- IPO Year
- TMCI 2021
- ETON 2018
- Fundamental
- Price
- TMCI $5.53
- ETON $13.57
- Analyst Decision
- TMCI Hold
- ETON Strong Buy
- Analyst Count
- TMCI 6
- ETON 3
- Target Price
- TMCI $9.18
- ETON $29.67
- AVG Volume (30 Days)
- TMCI 352.4K
- ETON 465.6K
- Earning Date
- TMCI 08-05-2025
- ETON 08-07-2025
- Dividend Yield
- TMCI N/A
- ETON N/A
- EPS Growth
- TMCI N/A
- ETON N/A
- EPS
- TMCI N/A
- ETON N/A
- Revenue
- TMCI $210,819,000.00
- ETON $48,327,000.00
- Revenue This Year
- TMCI $10.61
- ETON $103.21
- Revenue Next Year
- TMCI $10.36
- ETON $51.34
- P/E Ratio
- TMCI N/A
- ETON N/A
- Revenue Growth
- TMCI 7.54
- ETON 40.88
- 52 Week Low
- TMCI $4.54
- ETON $3.18
- 52 Week High
- TMCI $10.79
- ETON $21.48
- Technical
- Relative Strength Index (RSI)
- TMCI 34.86
- ETON 26.42
- Support Level
- TMCI $5.36
- ETON $13.20
- Resistance Level
- TMCI $6.28
- ETON $19.35
- Average True Range (ATR)
- TMCI 0.24
- ETON 0.93
- MACD
- TMCI -0.00
- ETON -0.49
- Stochastic Oscillator
- TMCI 16.30
- ETON 6.02
About TMCI Treace Medical Concepts Inc.
Treace Medical Concepts Inc is a commercial-stage orthopaedic medical device company. It is focused on advancing the standard of care for the surgical management of bunion deformities. The company's patented Lapiplasty 3D Bunion Correction procedure is designed to reproducibly correct all planes of the bunion deformity and address the root cause of the bunion, while allowing patients to return to their active lives quickly. The Company operates and manages its business as one segment, which is the business of designing, manufacturing, and marketing medical devices for physicians, surgeons, ambulatory surgery centers and hospitals.
About ETON Eton Pharmaceuticals Inc.
Eton Pharmaceuticals Inc is a United States based specialty pharmaceutical company. The company is engaged in developing and commercializing pharmaceutical products to fulfill an unmet patient need. It has four commercial rare disease products, Alkindi Sprinkle for the treatment of adrenocortical insufficiency; Carglumic Acid for the treatment of hyperammonemia, Betaine Anhydrous for the treatment of homocystinuria; and Nitisinone for the treatment of hereditary tyrosinemia type 1 (HT-1). The Company has three additional product candidates in late-stage development: ET-400, ET-600, and ZENEO hydrocortisone autoinjector.